Rare diseases
Investigational molecules
Locations
Safety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
AustriaStudy of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease
FranceEvaluating Gradual Interval Extension of Tezepelumab in Drug Combination for Patients with Severe Asthma
The NetherlandsStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
AustriaStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
AustriaStudy on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment
BulgariaStudy on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma
BelgiumStudy on the Effects of Benralizumab on Lung Function in Patients with Severe Eosinophilic Asthma
DenmarkStudy on Benralizumab and Mepolizumab for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) Receiving Standard Care
BelgiumStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
AustriaStudy on Benralizumab for Patients with Severe Asthma
FranceStudy on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
